These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 16965178)

  • 1. Designing siRNA that distinguish between genes that differ by a single nucleotide.
    Schwarz DS; Ding H; Kennington L; Moore JT; Schelter J; Burchard J; Linsley PS; Aronin N; Xu Z; Zamore PD
    PLoS Genet; 2006 Sep; 2(9):e140. PubMed ID: 16965178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of functional small interfering RNAs targeting amyotrophic lateral sclerosis-associated mutant alleles.
    Geng CM; Ding HL
    Chin Med J (Engl); 2011 Jan; 124(1):106-10. PubMed ID: 21362317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-mismatched siRNAs enhance selective gene silencing of a mutant ALS-causing allele.
    Geng CM; Ding HL
    Acta Pharmacol Sin; 2008 Feb; 29(2):211-6. PubMed ID: 18215350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.
    Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; Hohjoh H
    PLoS One; 2008 May; 3(5):e2248. PubMed ID: 18493311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis.
    Ding H; Schwarz DS; Keene A; Affar el B; Fenton L; Xia X; Shi Y; Zamore PD; Xu Z
    Aging Cell; 2003 Aug; 2(4):209-17. PubMed ID: 12934714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.
    Huang H; Qiao R; Zhao D; Zhang T; Li Y; Yi F; Lai F; Hong J; Ding X; Yang Z; Zhang L; Du Q; Liang Z
    Nucleic Acids Res; 2009 Dec; 37(22):7560-9. PubMed ID: 19815667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells.
    Maxwell MM; Pasinelli P; Kazantsev AG; Brown RH
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3178-83. PubMed ID: 14981234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The siRNA Non-seed Region and Its Target Sequences Are Auxiliary Determinants of Off-Target Effects.
    Kamola PJ; Nakano Y; Takahashi T; Wilson PA; Ui-Tei K
    PLoS Comput Biol; 2015 Dec; 11(12):e1004656. PubMed ID: 26657993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.
    Du Q; Thonberg H; Wang J; Wahlestedt C; Liang Z
    Nucleic Acids Res; 2005; 33(5):1671-7. PubMed ID: 15781493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing of highly effective complementary and mismatch siRNAs for silencing a gene.
    Ahmed F; Raghava GP
    PLoS One; 2011; 6(8):e23443. PubMed ID: 21853133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.
    Xia X; Zhou H; Huang Y; Xu Z
    Neurobiol Dis; 2006 Sep; 23(3):578-86. PubMed ID: 16857362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.
    Elbashir SM; Martinez J; Patkaniowska A; Lendeckel W; Tuschl T
    EMBO J; 2001 Dec; 20(23):6877-88. PubMed ID: 11726523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [RNAi and neurological disease].
    Yokota T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):973-5. PubMed ID: 16447777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-based inhibition specific for mutant SOD1 with single nucleotide alternation in familial ALS, compared with ribozyme and DNA enzyme.
    Yokota T; Miyagishi M; Hino T; Matsumura R; Tasinato A; Urushitani M; Rao RV; Takahashi R; Bredesen DE; Taira K; Mizusawa H
    Biochem Biophys Res Commun; 2004 Jan; 314(1):283-91. PubMed ID: 14715277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.
    Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR
    Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.
    Dua P; Yoo JW; Kim S; Lee DK
    Mol Ther; 2011 Sep; 19(9):1676-87. PubMed ID: 21673662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Silencing of L392V PSEN1 Mutant Allele by RNA Interference.
    Sierant M; Paduszynska A; Kazmierczak-Baranska J; Nacmias B; Sorbi S; Bagnoli S; Sochacka E; Nawrot B
    Int J Alzheimers Dis; 2011 Apr; 2011():809218. PubMed ID: 21559198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
    Naito Y; Yoshimura J; Morishita S; Ui-Tei K
    BMC Bioinformatics; 2009 Nov; 10():392. PubMed ID: 19948054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.